Abbvie (ABBV) PT Raised to $128 at Mizuho Securities
Tweet
Share
E-mailGet Alerts ABBV Hot Sheet
Price: $261.07 +3.99%
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
26 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Mizuho Securities analyst Vamil Divan raised the price target on Abbvie (NYSE: ABBV) to $128.00 (from $126.00) while maintaining a Buy rating.
You May Also Be Interested In
- A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
- Kraken Robotics (PNG:CN) (KRKNF) PT Lowered to Cdn$13.50 at Desjardins
- Societe BIC SA (BB:FP) (BICEY) PT Raised to EUR56 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
